Based on these findings, they speculated that the loss of TFF1 resulted in the epithelial–mesenchymal transition (EMT) of tumor cells and, therefore, upregulation of TFF1 might inhibit the EMT in cancer cells. The gene discussed is TFF1; the disease is cancer.